Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Buy
61,749
+35,352
+134% +$9.86M 2.44% 16
2025
Q4
$5.11M Sell
26,397
-36,792
-58% -$6.31M 5.11% 10
2025
Q3
$8.7M Sell
63,189
-52,327
-45% -$5.72M 7.33% 4
2025
Q2
$10.4M Sell
115,516
-3,590
-3% -$287K 8.35% 3
2025
Q1
$9.84M Buy
119,106
+46,863
+65% +$5.24M 8.52% 4
2024
Q4
$9.1M Buy
72,243
+34,328
+91% +$4.06M 7.55% 5
2024
Q3
$5.08M Buy
37,915
+30,000
+379% +$4.04M 3.84% 15
2024
Q2
$1.17M Buy
+7,915
New +$1.01M 0.91% 23

Other funds holding TER

XXEC Inc's TER Position: Q1 2026 in Review

XXEC Inc increased its Teradyne (TER) stake by 134% in Q1 2026, buying an estimated $9.86M and bringing the position to 61,749 shares worth $13.9M. The position accounts for 2.44% of the portfolio, ranked #16.

XXEC Inc first reported a position in TER in Q2 2024 and has held it in 8 quarters since. 1,223 funds tracked by Wall St. Rank hold TER as of Q1 2026.

  • XXEC Inc held 61,749 shares of Teradyne worth $13.9M as of Q1 2026.
  • XXEC Inc bought 35,352 Teradyne shares in Q1 2026, an estimated $9.86M.
  • Teradyne made up 2.44% of XXEC Inc's portfolio in Q1 2026, its #16 holding.
  • XXEC Inc first reported a position in Teradyne in Q2 2024 and has held it in 8 quarters since.
  • 1,223 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on XXEC Inc's 13F filing for Q1 2026, filed 24 Apr 2026.